308 related articles for article (PubMed ID: 34016281)
1. Antifungals in Clinical Use and the Pipeline.
Johnson MD
Infect Dis Clin North Am; 2021 Jun; 35(2):341-371. PubMed ID: 34016281
[TBL] [Abstract][Full Text] [Related]
2. [Antifungals for systemic use].
Ruiz-Camps I; Cuenca-Estrella M
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):353-62. PubMed ID: 19482382
[TBL] [Abstract][Full Text] [Related]
3. Recent approaches to antifungal therapy for invasive mycoses.
Mathew BP; Nath M
ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
[TBL] [Abstract][Full Text] [Related]
4. Management of invasive fungal infections: a role for polyenes.
Chandrasekar P
J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
[TBL] [Abstract][Full Text] [Related]
5. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.
Lyman CA; Walsh TJ
Drugs; 1992 Jul; 44(1):9-35. PubMed ID: 1379913
[TBL] [Abstract][Full Text] [Related]
6. Drugs in Clinical Development for Fungal Infections.
Gonzalez-Lara MF; Sifuentes-Osornio J; Ostrosky-Zeichner L
Drugs; 2017 Sep; 77(14):1505-1518. PubMed ID: 28840541
[TBL] [Abstract][Full Text] [Related]
7. Current options in antifungal pharmacotherapy.
Mohr J; Johnson M; Cooper T; Lewis JS; Ostrosky-Zeichner L
Pharmacotherapy; 2008 May; 28(5):614-45. PubMed ID: 18447660
[TBL] [Abstract][Full Text] [Related]
8. Systemic antifungal agents. What is in the pipeline?
Kauffman CA
Drugs R D; 1999 Feb; 1(2):153-9. PubMed ID: 10566012
[TBL] [Abstract][Full Text] [Related]
9. The value of amphotericin B in the treatment of invasive fungal infections.
Klepser M
J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
[TBL] [Abstract][Full Text] [Related]
10. Recent drug development and treatments for fungal infections.
Roy M; Karhana S; Shamsuzzaman M; Khan MA
Braz J Microbiol; 2023 Sep; 54(3):1695-1716. PubMed ID: 37219748
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
Jullien V
Arch Pediatr; 2011 May; 18 Suppl 1():S42-7. PubMed ID: 21596286
[TBL] [Abstract][Full Text] [Related]
12. [Antifungal resistance in opportunistic pathogenic fungi (I). Polyenes and fluorocytosine].
Martínez-Suárez JV; Rodríguez-Tudela JL
Enferm Infecc Microbiol Clin; 1996; 14(6):384-9. PubMed ID: 8756218
[No Abstract] [Full Text] [Related]
13. Antifungal treatment in pediatric patients.
Zaoutis TE; Benjamin DK; Steinbach WJ
Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
[TBL] [Abstract][Full Text] [Related]
14. Antifungal drug resistance mechanisms.
Pemán J; Cantón E; Espinel-Ingroff A
Expert Rev Anti Infect Ther; 2009 May; 7(4):453-60. PubMed ID: 19400764
[TBL] [Abstract][Full Text] [Related]
15. Current status and future of antifungal therapy for systemic mycoses.
Nosanchuk JD
Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):75-84. PubMed ID: 18221136
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic implications for use of antifungal agents.
Lewis RE
Curr Opin Pharmacol; 2007 Oct; 7(5):491-7. PubMed ID: 17616480
[TBL] [Abstract][Full Text] [Related]
17. Antifungal pharmacokinetics and pharmacodynamics.
Lepak AJ; Andes DR
Cold Spring Harb Perspect Med; 2014 Nov; 5(5):a019653. PubMed ID: 25384765
[TBL] [Abstract][Full Text] [Related]
18. Clinical indications for newer antifungal agents.
Naeger-Murphy N; Pile JC
J Hosp Med; 2009 Feb; 4(2):102-11. PubMed ID: 19219926
[TBL] [Abstract][Full Text] [Related]
19. Antifungal drugs.
Treat Guidel Med Lett; 2005 Feb; 3(30):7-14. PubMed ID: 15671963
[No Abstract] [Full Text] [Related]
20. Clinical pharmacology of antifungal compounds.
Groll AH; Gea-Banacloche JC; Glasmacher A; Just-Nuebling G; Maschmeyer G; Walsh TJ
Infect Dis Clin North Am; 2003 Mar; 17(1):159-91, ix. PubMed ID: 12751265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
